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In the pediatric clinic, nutritional research is focusingmore andmore onpreventing the development of long-termdiseases aswell as
supporting the repair processes important in the therapy of already fully developed diseases. Most children who are hospitalized or
affected by chronic diseases could benefit from specific and careful attention to nutrition. Indeed, the state of nutrition modulates
all body functions, including the different metabolic processes which, all together, have a profound effect on the development
of the health and future of all individuals. Inappropriate food, even in the first periods of life, can accelerate the development of
chronicmetabolic diseases, especially in the pediatric age. To gain further insights intometabolic cycles and how they are connected
with diet and health, nutrition and metabolomics interact to develop and apply modern technologies for metabolic assessment. In
particular, nutritionists are evaluating the metabolomic approach to establish the single nutritional phenotypes, that is, the way
in which diet interacts with individuals’ metabolisms. This strategy offers the possibility of providing a complete definition of the
individual’s nutritional and health status, predict the risk of disease, and create metabolomic databases supporting the development
of “personalized nutrition,” in which diet is attuned to the nutritional needs of individual patients.
1. Introduction
Metabolomics, one of the most recent “omics” sciences, can
be defined as an approach based on the systematic study of the
complete set of metabolites (metabolome) present in a given
biological system, whether fluids, cells, or organisms [1]. The
metabolome represents the complete set of low molecular
weight (typically < 1500Da) metabolites produced by an
organism, which are the end products of gene expression.
Thus, it can be viewed as a mirror that reflects the physiologi-
cal, evolutionary, andpathological state of a biological system.
By measuring the metabolome, metabolomics allows us to
photograph the genome in its interaction with the environ-
ment and thus investigate themetabolic status of an organism
in determined physiological conditions as a consequence of
drug treatment, environmental influences, nutrition, lifestyle,
genetic effects, and so on.Metabolomic analyses can generally
be classified as targeted or untargeted. Targeted analyses focus
on the characterization of a specific class of metabolites and
are used to measure the concentration of a limited number
of known metabolites precisely. This approach is important
for assessing the behavior of a specific group of com-
pounds in the sample under given conditions. Untargeted
metabolomics focuses on the analysis of the metabolome
profile to obtain fingerprints without attempting to identify
or precisely quantify all the metabolites in the sample. This
approach is most useful in biomarker discovery, diagnostics,
and revealing specificmetabolic patterns of disease.The study
of the complex metabolic fingerprint and the comparative
analyses of metabolomes are performed by a combined
approach of spectrometric and spectroscopic techniques and
computer programs. The techniques commonly employed
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are nuclear magnetic resonance (NMR) spectroscopy, gas or
liquid chromatography-mass spectrometry (GC-MS and LC-
MS), Fourier transform infrared spectrometry, and capillary
electrophoresis-MS (CE-MS). One of the difficulties with all
these techniques is that they provide complex datasets, due
to the large numbers of metabolites generated by multiple
subjects. Thus, the analysis and interpretation of data relies
on pattern recognition and discriminant analysis techniques
[2]. One of the areas of greatest interest and in which
metabolomics has revealed its great potential is that of
nutrition. This is at the origin of nutrimetabolomics or
nutritional metabolomics, that is, the study of the human
or animal metabolome as a function of nutritional status or
as a function of a nutritional challenge. Nutrimetabolomics,
together with nutrigenomics, is the foundation on which
personalized diets are shaped and planned: through the
study of the metabolome it is possible to assess changes
induced by diet in gene expression and thus, by modifying
the nutriments and biomolecules assumed in the diet, we
can intervene in the interaction between nutrients and the
human metabolism to reach and maintain the best state
of health [3, 4]. Thanks to metabolomics, it appears to
be possible to assess an individual’s state of nutrition to
understand how single nutrients influence metabolic reg-
ulation and thus to formulate personalized diets which, if
followed at an early age, may prevent the onset of certain
chronic diseases such as diabetes, inflammatory diseases,
and obesity. Nutrimetabolomics appears to be a promising
technique also in pediatric and neonatal research. Studies in
this field are evolving continuously towards an improvement
in pediatric and neonatological practices in hospitals and
clinics. It has been found more and more that exogenous
factors such as nutrition, especially in the early stages of life,
are of fundamental importance owing to their impact on
the proper growth of children and their possible implication
for diseases in adulthood, in the case of an inappropriate
diet [5]. Comprehension of changes in metabolic profiles
during one’s lifespan, starting from the earliest stages, may
represent an important point of reference in arriving at an
understanding of their fundamental mechanisms and their
consequent metabolic alterations. This review focuses on the
applications of metabolomic technology in the context of
neonatology and pediatrics with emphasis on the potential
preclinical and clinical applications of this technology in the
area of nutrition.
2. Metabolomics and Nutrition in Neonatology
In the last ten years, many steps forward have been taken
by experts in the field of nutrition in identifying nutrients
essential for the growth and good health of the newborn.
Milk is a key component in the diet of infants all over
the world and especially breast milk is the primary source
of nutrition for neonates. Human breast milk (HBM) is a
complex biological fluid capable of satisfying the nutritional
requirements of a rapidly growing child. Besides the normal
nutritional substances such as proteins, carbohydrates, fats,
vitamins, and minerals, HBM also contains many other bio-
logically active components such as growth factors, antimi-
crobic compounds, and immunostimulating components
that educate neonates’ immune system and protect them
against pathogens [6, 7]. Many studies have demonstrated
the advantages of breastfeeding, especially in the case of
preterm neonates who, because of their low weight at birth,
are more exposed to the onset of diseases, both in the first
months of life and in adulthood [8, 9]. For these patients, it is
thus important to have the best possible nutritional support
to ensure proper growth and long-term effects on health
and wellbeing. Recently, NMR-based metabolomic studies
have been performed to better understand the nutritional
properties of HBM. The first investigation was carried out
by Marincola et al. [10] who compared the metabolic profiles
of the hydrosoluble extract from breast milk of mothers who
gave premature birth (between 26 and 36 weeks of gestation)
with those of formula milk. A detailed NMR spectral analysis
of the human milk oligosaccharides (HMOs) was performed
by Pratico` et al. [11]. Finally, Smilowitz et al. [12] investigated
the interindividual variation in themilkmetabolome in terms
of maternal secretor status, phenotype, and diet. All of these
studies pointed out the contribution of several factors to
milk composition variation, among which time of collection,
mother’s diet and length of pregnancy.
At present, nutritionists and dietologists are turning their
attention to the discovery of new ways to treat or prevent
diseases connected with nutrition such as obesity, diabetes,
cardiovascular diseases, and themetabolic syndrome. Several
studies have demonstrated that certain chronic pathologies
are caused not only by postnatal conditions but also by
exposure to epigenetic factors that may influence and per-
manently alter fetal “programming” [13–15]. It would in fact
appear that fetalmalnutrition, both excessive and insufficient,
may permanently alter the metabolic processes of the fetus
and increase the risk of chronic diseases in adulthood [5].
An altered glucid metabolism during fetal development in
neonates with intrauterine growth retardation (IUGR) has
recently been suggested to be reflected by the increase in
extracellular myoinositol that may be considered a valid
predictive marker of the development of obesity and type
2 diabetes (T2D) in adulthood [16, 17]. Inositol is in fact
known as a secondary messenger of the insulin transducer
signal; it is also known that insulin plays a role in favoring
lipid and provide synthesis as well as cell growth [18]. In the
case of fetal malnutrition (both too much and not enough),
it is thus possible to hypothesize that at birth there is a
situation of reduced sensitivity to insulin which may be
revealed by an increase in extracellular inositol. Recently,
the metabolomics approach has been adopted to analyze
the urine NMR profiles in large-for-gestational-age (LGA)
and IUGR neonates and to define the metabolic patterns
associated with such pathologies [19]. The metabolomic
analysismade it possible to identifymolecules responsible for
the different metabolic profiles of IUGR and LGA newborns
with respect to a control group. Among these metabolites,
myoinositol stood out, whose urine content was higher
in both IUGR and LGA neonates. This finding appears
to confirm the fact that exposure to a hyperglycemic or
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hypoglycemic environment in the uterus leads to a common
condition of reduced glucid tolerance at birth which tends to
persist during growth and into adulthood and consequently
to a higher risk of developing pathologies such as obesity and
T2D (Figure 1).Thus, comprehension of changes inmetabolic
profiles during one’s lifespan, starting from the earliest stages,
may represent an important point of reference in arriving at
an understanding of their fundamentalmechanisms and their
consequent metabolic alterations. Indeed, if it is true that
genetics regulates an individual’s response to food (nutrige-
netics), it is being more and more affirmed that nutrients can
control the gene expression (nutrigenomics) and products of
the metabolism (nutrimetabolomics).
3. Metabolomics and Nutrition in Pediatrics
A number of studies applying metabolomics to nutritional
research in pediatrics have been performed (Table 1).
Bertram et al. [20] were the first to demonstrate the potential
of NMR-based metabolomics in identifying the overall bio-
chemical effects of consumption of different animal proteins
in children. In their work the authors investigated the
biochemical effects and metabolic differences linked with
assumption of large amounts of milk or meat proteins for a
limited period of time in children eight years of age. They
discovered that the diet based on milk protein generated an
increase in urinary excretion of hippurate (mainly derived
via gut microfloral breakdown of plant phenolics and aro-
matic amino acids), thus demonstrating alterations in gut
microflora. Differently, the meat diet caused increased uri-
nary excretion of creatine and histidine, whose presence is
consistent with the fact that meat is the primary creatine
and histidine source, and urea. The NMR analysis of serum
revealed a slight influence of the milk diet on the lipid pro-
file, while the meat diet appeared not to have any effect
on the serum metabolic profile. These findings confirmed
that the metabolomic phenotype is the result not only of
genetic factors and diet, but also of the individual’s intestinal
microbiome. How nutritional habits interfere with the
intestinal microbiota is far from understood. The human
body contains thousands of millions of microorganisms.
They are greater in number than the cells and represent
about 3% of body mass. For example, the bacteria that live
in the intestinal tract make it possible to digest food and
absorb nutritional substances by decomposing most of
the proteins, lipids and carbohydrates in our diet, which
otherwise would not be assimilated. The microbiome is able
to contribute to human survival, with a larger number of
genes compared to those of humans themselves. Several
experts have hypothesized that a person’s intestinal flora has
a specific metabolic efficiency and that certain characteristics
of microbiome composition may predispose towards a group
of obesity-related metabolic abnormalities that increase
an individual’s risk of developing type 2 diabetes and
cardiovascular disease [21]. Even though the microbiome
of each individual begins at birth, it is possible to modify
its composition through variations in the diet. It has been
demonstrated that the kind of diet is capable of modifying
certain risk factors for the development of the metabolic
syndrome in obese individuals by causing variations in
the composition of the bacterial population. In the light
of a relationship among obesity, microbiome, and major
susceptibility to the metabolic syndrome, it is thus clear that
diet assumes a central role in modulating the risk of the
disorder.
Infantile obesity is one of the most frequent problems in
the pediatric age. The risk of an obese child becoming an
obese adult increases with age and is directly related to the
amount of excess weight. Moreover, an association between
a rapid weight increase in early infancy and an increased
risk of obesity in adulthood has been found [22]. Since
obesity predicts both short- and long-term adverse health
outcomes, including T2D, cardiovascular diseases, hyperten-
sion, certain forms of cancer and other obesity-associated
problems, research into early-life determinants of obesity
could lead to innovative strategies for prevention. Different
metabolomic investigations both on animals and humans
have been performed on themetabolic state of obese children.
As will be shown shortly, since growth might have an impact
onmetabolism, data in the literature onmetabolomic changes
related to obesity show some inconsistencies, especially when
a comparison between adults and children is made. Mihalik
et al. [23] performed a targetmetabolomic study to determine
whether or not obese youth with or without T2D would
show the fasting plasma metabolic signatures of elevated
amino acid (AA) and medium- to short-chain acylcarnitine
(AcylCN) species reported in adults. To this end, tandem
mass spectrometry (MS/MS) was used to assess the con-
centration of AcylCN species and AA in plasma of obese
(OB), normal weight (NW), and T2D obese adolescents. The
findings demonstrated that long-chain AcylCNs were similar
in the three groups. Differently, short- and medium-chain
AcylCN and AA concentrations were lower in the plasma
of both the OB and the diabetic youths. Furthermore, OB
adolescents with T2D demonstrated lower concentrations of
the later 𝛽-oxidation intermediates along with higher rates of
fat oxidation. Contrary to what has been reported for adults,
the absence of defective fatty acid or amino acid metabolism
in OB and T2D adolescents compared with NW support the
hypothesis that adolescents and young adults with obesity
and T2D have not yet developed the mitochondrial defects
that are documented in older adults, and they may even have
enhanced mitochondrial activity as an adaptation.
Plasma samples from normal weight, overweight and
obese childrenwere profiled by Zeng et al. [24] usingGC-MS.
Several metabolites (isoleucine, glyceric acid, serine, 2,3,4-
trihydroxybutyric acid, and phenylalanine) were screened
as potential biomarkers of childhood obesity. Moreover, the
waist-hip ratio together with total triglycerides, total choles-
terol, high density lipoprotein and low density lipoprotein
were suggested to be the most important parameters that
correlated with the metabolic disturbances of childhood
obesity. Wahl et al. [25] analysed serum samples of OB and
NW children between 6 and 15 years of age by using a MS-
based metabolomics approach. Metabolite concentrations
andmetabolite ratios were compared between the two groups
of children as well as between children of different pubertal
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Figure 1: Nutrimetabolomics, nutrigenomics, and nutrigenetics in the life cycle: between genetics and environment and between hypo- and
hypernutrition.
stages. Fourteen metabolites and 69 metabolite ratios were
found to be significantly different in OB compared to NW
children. In particular, the observed higher concentrations
of the acylcarnitines in OB compared to NW were con-
sistent with findings in adults. Differently, a significant
reduction of glutamine, methionine, proline, and acyl-alkyl
phosphatidylcholine (PC) concentrations was found in OB
compared to NW children. Furthermore, OB children exhib-
ited significantly decreased concentrations of the unsatu-
rated lysophosphatidylcholines (LPCs) and increased ratios
between saturated LPCs and phatidylcholines. The identified
biomarkers were indicative of oxidative stress and changes in
sphingomyelin metabolism, in 𝛽-oxidation, and in pathways
associated with energy expenditure.
In the search for weight loss predictors, Wahl et al.
[26] analyzed the MS serum metabolite profile of obese
children during the Obeldicks lifestyle intervention program,
a one-year weight loss program tailored to obese children
aged 6–15 years and based on physical activity, nutritional
education and behavior therapy that includes individual
psychological care of the child and his/her family. Eighty
obese children completed the Obeldicks program and were
analyzed: 40 achieved a substantial reduction of their body
mass index standard deviation score (BMI-SDS) during
this program and 40 did not improve their overweight
status. The combination of MS data with anthropometric
and clinical parameters highlighted long-chain unsaturated
phosphatidylcholines and smaller waist circumference as
significant predictors of BMI-SDS reduction during the study,
thus suggesting a role of phosphatidylcholine metabolism
and abdominal obesity in bodyweight regulation. To enhance
the understanding of relationships between obesity and gut
microbiota, lifestyle and genetic background in humans,
some animal species have been evaluated as experimental
models for obesity research. Because of similarities in nutri-
tion and metabolism between pigs and humans [12, 13],
genetically obese and lean pigs are useful in childhood obesity
research in understanding the mechanisms responsible for
development of adiposity. He et al. [27] used NMR-based
metabonomics to investigate differences in the serum of
genetically obese and lean growing pigs to explore the
feasibility of using the obese Ningxiang pig as an animal
model for childhood obesity research. The results of this
study clearly demonstrated marked differences in serum
metabolites, hormones and body composition between obese
and lean pigs under the same nutritional and environmental
conditions.The altered serummetabonome of obese pigs was
mainly ascribed to increased lipogenesis, adipose accumula-
tion, reduced conversion of amino acid nitrogen into urea,
and reduced protein synthesis. In addition, changes in gut
microbiota-related metabolites, including trimethylamine-
N-oxide and choline, were observed in sera of obese pigs
compared to lean pigs. Most of these changes are similar
to those reported for other animal models as well as chil-
dren and teenagers. These findings justify the use of the
Ningxiang pig as an animal model for childhood obesity
research.
Increasing rates of obesity in children have focused
attention also on the development of type 1 diabetes (T1D).
Indeed, the risk of T1D might rise with increased weight
gain as a result of increased insulin resistance and additional
stress to beta cells [28]. Zuppi et al. [29] were the first to test
the potential of NMR-based metabolomics in highlighting
differences between urines from children and adolescents
with T1D, but without renal complications, and from healthy
individuals matched for sex and age. The levels of alanine,
lactate, acetate and citrate were significantly higher in the
diabetic patients than in controls. No correlation was found
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between the duration of T1D and the urinary excretion of
the different metabolites. This result was hypothesized to
reflect the increased glomerular filtration rate and/or mod-
ification of the transport mechanism at the tubular lumen
in T1D. Changes in the serum metabolome were assessed
prospectively in children who later progressed to T1D by
Oresic et al. [30]. For this study, ultraperformance liquid
chromatography coupled to mass spectrometry (UPLC-MS)
was used.The authors compared the serummetabolome from
children who, during followup, progressed to type 1 diabetes-
associated autoimmunity and, further, to clinical diabetes
or who remained permanently healthy and autoantibody
negative. The individuals who developed diabetes had low
serum levels of succinic acid and PC at birth, reduced
levels of triglycerides and antioxidant ether phospholipids
throughout the follow up, and increased levels of proin-
flammatory lysoPCs several months before seroconversion
to autoantibody positivity. The appearance of insulin and
glutamic acid decarboxylase autoantibodies was preceded by
diminished ketoleucine and elevated glutamic acid. These
findings strongly suggested that the metabolic dysregulation
precedes overt autoimmunity in T1D.
Balderas et al. [31] used capillary electrophoresis with UV
detection to reveal differences in urines of diabetic children
as compared to controls and to study the effects of a special
additive containing rosemary extract, vitamin E and polyun-
saturated fatty acids added to their standard diet through the
meat. Analysis of urines obtained after a 12-month treatment
evidenced clear differences between treated and nontreated
diabetic children. Some of the metabolites associated with
T1D were identified, among which guanidinoacetate, creati-
nine, urea, phenyllactate and p-OH-phenyllactate, phenace-
turate, and benzoate. To analyze more in depth the metabolic
changes characterizing T1D children, Balderas et al. [32]
later also investigated the alterations in plasma and urine
of T1D diabetic children who were under insulin treatment
with good glycemic control. Plasma samples were analyzed
with LC-MS, while urines with CE-MS. Compared to the
control group, the main changes in plasma of T1D patients
were associated with the lipid metabolism and some markers
of the differential activity of the gut microflora. Changes
in urine composition were associated with the protein and
amino acid metabolism. Furthermore, one early glycation
end product (fructosamine) was excreted in higher propor-
tion in the diabetic group. A detailed analysis of the NMR-
basedmetabolomics profiles of diabetic and healthy children’s
urine was presented by Culeddu et al. [33]. By excluding
from the statistical analysis the NMR signals of sugars and
citrate (related to the carbohydrate metabolism) and of
hippurate (a metabolite of bacterial origins) whose presence
overwhelmed all the other compound effects on classification
models, the authors evidenced other metabolites (p-cresol
sulphate and phenylacetylglycine) as relevant biomarkers.
These metabolites were suggested to reflect changes in gut
microbiota composition of T1D children with respect to the
control group. Additional urine biomarkers associated with
T1D were found by Deja et al. [34]. They investigated the
relation between the level of glycated hemoglobin (HbA1c)
and concentration of metabolites in urines of T1D children
and teenagers by using 1H NMR target analysis. Differences
among patients with HbA1c levels below (L-T1D) and above
(H-T1D) 6.5% showed the importance not only of glucose,
ketone bodies and HbA1c, but also of other urine metabolites
such as alanine, valine, acetate, pyruvate and citrate, probably
related to the endogenous glucose production pathway from
proteins.
Recently, the biochemical conditions at the root of inflam-
matory intestinal disease and their impact on the systemic
and gastrointestinal metabolism was studied by Baur et al.
[35]. The authors monitored the metabolic events associated
with the progressive development of Crohn’s disease in a
mouse model (from the age of 4 up to 24 weeks). The
metabolic profiles of different intestinal compartments were
generated by combining NMR spectroscopy and LC-MS.
Data revealed shifts in the intestinal lipid metabolism con-
comitant with the histological onset of inflammation. More-
over, the condition of advanced diseasewas characterized by a
significantly altered metabolism of cholesterol, triglycerides,
phospholipids and sphingomyelin in the inflamed tissue
(ileum) and the adjacent parts of the intestine (proximal
colon). Finally, the effects of nutrition on the metabolic
and kinetic equilibrium in children affected by the celiac
disease (CD) were assessed in ametabolomic work by Sellitto
et al. [36]. The authors combined high-resolution culture-
independent methods based on pyrosequencing of barcoded
16SrRNA gene amplicons, quantitative PCR and NMR-based
metabolomics to determine the composition and temporal
changes of the gut microbiota and to identify potential
biomarkers associated with onset of CD in infants with
genetic predisposition for CD over the first two years of life.
The results showed that infants genetically susceptible to CD
who were exposed to gluten at an early age mounted an
immune response against gluten and developed CD autoim-
munity more frequently than at-risk infants in which gluten
exposure was delayed until 12 months of age. Furthermore,
the metabolomic analysis of fecal samples revealed potential
biomarkers for the prediction of the disease.
4. Conclusions
On the basis of published studies, it can be stated thatmetabo-
lomics is showing itself to be a powerful investigative tool
in pediatric and neonatological nutrition research and, in
particular, in searching for new biomarkers associated with
nutritional health and/or disease status. The final goal is to
arrive at an understanding of the biological behavior of a
cell system in response to outside stimuli and clear the way
to a comprehension of the complex network of interactions
between nutrients and molecules (nutrimetabolomics). It is
the study of cell metabolites of low molecular weight in
response to dietetic treatments that will make it possible to
design a kind of nutrition tailored to the genes of each indi-
vidual, especially in the fields of neonatology and pediatrics.
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